Phenylbutazone 20% (Canada)

This page contains information on Phenylbutazone 20% for veterinary use.
The information provided typically includes the following:
  • Phenylbutazone 20% Indications
  • Warnings and cautions for Phenylbutazone 20%
  • Direction and dosage information for Phenylbutazone 20%

Phenylbutazone 20%

This treatment applies to the following species:
Manufacturer: Rafter 8

phenylbutazone injection, USP

Sterile

DIN 02333716

For Veterinary Use Only

WARNINGS: KEEP OUT OF REACH OF CHILDREN. This drug is not to be administered to horses that are to be slaughtered for use in food.

Active Ingredient

(per mL): 200 mg phenylbutazone

Preservatives (per mL): 1 mg methyl parahydroxybenzoate; 0.1 mg propyl parahydroxybenzoate

Phenylbutazone 20% Indications

Dog: As an aid in the treatment of bursitis, osteoarthritis, arthritis, posterior weakness, posterior paralysis, rheumatism, inflammation of the skin and other soft tissues.

Horse: As an aid in the treatment of osteoarthritis of medial and distal bones of the hock, arthritis of the stifle and hip, arthritis of spine, chronic hip pains, chronic pain in trapezius muscles and generalized arthritis.

Dosage and Administration

Inject slowly, intravenously.

Dog: 0.5 mL (100 mg) per 5 kg body weight daily. Total daily dosage should not exceed 4 mL, regardless of weight. Do not treat intravenously for more than 2 consecutive days.

Horse: 2.5-5 mL (0.5 - 1 g) per 250 kg body weight daily. Total daily dose should not exceed 20 mL, regardless of weight. Do not treat intravenously for more than 5 consecutive days.

Contraindications

Do not administer to animals with cardiac, renal or hepatic disease or those with evidence of hemocytological disorders.

Phenylbutazone 20% Caution

Once the condition has regressed, treat strictly as required or as recommended by a veterinarian. If no response is noted within 5 days, the treatment should be discontinued and the diagnosis should be re-evaluated. Care should be taken to avoid perivascular administration due to possible swelling, necrosis and sloughing at the injection site. Stop medication at first sign of gastrointestinal upsets, jaundice or blood dyscrasia. When inflammatory conditions are caused by microorganisms, adequate therapy should be given simultaneously with phenylbutazone.

Storage

Store below 25°C. Keep from freezing. Protect from light.

100 mL

Rafter 8 Products Inc., 4746-14 Street NE, Calgary, AB T2E 6L7

NAC No.: 12190290

RAFTER 8 PRODUCTS
4746 14TH STREET N.E., CALGARY, AB, T2E 6L7
Telephone:   403-291-3640
Order Desk:   800-461-8615
Fax:   403-250-2703
Website:   www.rafter8.ca
Email:   orders@rafter8.ca
Every effort has been made to ensure the accuracy of the Phenylbutazone 20% information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-05-28

(web3)